|
| |
| | | 52510 | | 21.10.1994 | | Pfizer AG | | 18.02.2004 | | | | | | | | | | | 02.04.50. | | | | 05.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Caverject 20 ug | Injektionspräparat | Injection preparation () | G04BE01 | CI | | 02 | Caverject 10 ug | Injektionspräparat | Injection preparation () | G04BE01 | CI | | 03 | Caverject 20 ug | Injektionspräparat | Injection preparation (Alprostadil 20 µg) + Injection preparation () | G04BE01 | CI | | 04 | Caverject 10 ug | Injektionspräparat | Injection preparation (Alprostadil 10 µg) + Injection preparation () | G04BE01 | CI |
|
|
|
